Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

NCT03642210 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Medicines360